BML Capital Management, LLC
•CIK: 1616824•Filing: Q4 2025
BML Capital Management, LLC is an actively managed fund overseeing $116M across 16 distinct positions. The portfolio exhibits significant concentration, with ACRS anchoring the top holding at $42.9M, followed by AVIR at $26.7M. Notable allocations include ORMP ($9.0M) and TIL ($7.1M), suggesting targeted exposure across specific sectors. This structure indicates a concentrated, conviction-driven investment approach within its current mandate.
Total AUM
$113.0M
+ $2.7M in options
QoQ Performance
+3.9%
Positions
13
+ 3 options
Top 10 Concentration
95.6%
Latest Filing
Q4 2025
Top Holdings Allocation
ACRS
AVIR
ORMP
TIL
PMVP
KMX
ACRS37.1%
AVIR23.1%
ORMP7.8%
TIL6.1%
PMVP5.7%
KMX5.2%
KZR3.9%
DYH3.2%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other99.4%
Consumer0.6%
🚪 Exited Positionssold since Q3 2025
—
ADVERUM BIOTECHNOLOGIES INC
SOLD
$13.9M
—
LAVA THERAPEUTICS NV
SOLD
$3.1M
+3 more exited positions
Changes from Q3 2025
NEW5 new positions
↑3 increased
↓3 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023